NCT06599762 2026-04-22
MYELO-CAN:TXA
University of Manitoba
Phase 2 Recruiting
Clinical Trials
8 trialsNCT06886516 2026-04-15
Apixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
Phase EARLY_PHASE1 Recruiting
NCT07441720 2026-03-02
Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)
Zhejiang Cancer Hospital
Phase 2 Recruiting
NCT05255003 2025-12-17
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Ottawa Hospital Research Institute
Phase 4 Recruiting
NCT07257809 2025-12-02
Herombopag Treated T-DM1 Induced Platelet Reduction
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT07110090 2025-09-09
Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Recruiting
NCT06245746 2025-03-21
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1 Recruiting
NCT06433830 2024-05-30
Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy
Sir Run Run Shaw Hospital
Phase 2 Recruiting